Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

A new peer-reviewed study based on data from nearly 2M individuals highlights a wide range of clinical benefits and risks, ...

As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

VHC Health’s Dr. Arshad Ali and WebMD’s Dr. John Whyte talk weight management and simplify the information surrounding GLP-1 ...